These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 8402464)

  • 41. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB; Zeng FH; Sun ZQ
    Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nuclear morphometry for improved prediction of the prognosis of human bladder carcinoma.
    Fukuzawa S; Hashimura T; Sasaki M; Yamabe H; Yoshida O
    Cancer; 1995 Nov; 76(10):1790-6. PubMed ID: 8625049
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic criteria in patients with prostate cancer: correlation with volume weighted mean nuclear volume.
    Fujikawa K; Sasaki M; Aoyama T; Itoh T; Yoshida O
    J Urol; 1995 Dec; 154(6):2123-7. PubMed ID: 7500473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
    Krüger S; Müller H
    Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Volume-corrected mitotic index and mitotic activity index in transitional cell bladder cancer.
    Lipponen PK; Eskelinen MJ
    Eur Urol; 1990; 18(4):258-62. PubMed ID: 2289518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereological estimates of nuclear volume and other quantitative variables in supratentorial brain tumors. Practical technique and use in prognostic evaluation.
    Sørensen FB; Braendgaard H; Chistiansen AO; Bojsen-Møller M; Reske-Nielsen E
    J Neurooncol; 1991 Jun; 10(3):253-62. PubMed ID: 1654405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of volume weighted mean nuclear volume for predicting disease outcome in patients with renal cell carcinoma.
    Fujikawa K; Sasaki M; Aoyama T; Itoh T
    J Urol; 1997 Apr; 157(4):1237-41. PubMed ID: 9120910
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognostic factors in 243 transitional carcinomas of the bladder (II): microscopic parameters of the tumor and staging].
    Portillo Martín JA; Val Bernal F; Garijo Ayenza F; Buelta Carrillo L; Martín García B; Hernández Rodríguez R; Gutiérrez Baños JL; Correas Gómez MA; Concepción Masip T; Fernández Gómez JM
    Arch Esp Urol; 1991 Mar; 44(2):161-8. PubMed ID: 1867491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereologic, histopathologic, flow cytometric, and clinical parameters in the prognostic evaluation of 74 patients with intraoral squamous cell carcinomas.
    Bundgaard T; Sørensen FB; Gaihede M; Søgaard H; Overgaard J
    Cancer; 1992 Jul; 70(1):1-13. PubMed ID: 1606528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic comparison of proliferation markers and World Health Organization 1973/2004 grades in urothelial carcinomas of the urinary bladder.
    Mangrud OM; Gudlaugsson E; Skaland I; Tasdemir I; Dalen I; van Diermen B; Baak JP; Janssen EA
    Hum Pathol; 2014 Jul; 45(7):1496-503. PubMed ID: 24796506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of proliferative activity and nuclear morphometry for progression in TaT1 urothelial cell carcinomas of the urinary bladder.
    Bol MG; Baak JP; Rep S; Marx WL; Kruse AJ; Bos SD; Kisman O; Voorhorst FJ
    Urology; 2002 Dec; 60(6):1124-30. PubMed ID: 12475695
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Further testing of morphometric grading in T(A,1) urothelial carcinomas of the urinary bladder and the additional value of p53 immunoquantitation.
    Bol MG; Baak JP; Janssen EA; Breeuwsma NG; de Bruin PC
    Anal Quant Cytol Histol; 2002 Apr; 24(2):114-20. PubMed ID: 12026049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
    Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
    Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Histological and quantitative prognostic factors in transitional cell bladder cancer treated by cystectomy.
    Lipponen PK
    Anticancer Res; 1992; 12(5):1527-32. PubMed ID: 1444216
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
    Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
    Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Surgical treatment for 217 patients with bladder transitional carcinoma].
    Yu SL; Zhou FJ; Qin ZK; Han H; Liu ZW; Wang B; Wang H; Li YH
    Ai Zheng; 2006 Jan; 25(1):73-5. PubMed ID: 16405754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Volume corrected mitotic index (M/V index) in human bladder cancer; relation to histological grade (WHO), clinical stage (UICC) and prognosis.
    Lipponen PK; Collan Y; Eskelinen MJ; Pesonen E; Sotarauta M
    Scand J Urol Nephrol; 1990; 24(1):39-45. PubMed ID: 2320971
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index.
    Lipponen PK; Eskelinen MJ; Jauhiainen K; Harju E; Terho P; Haapasalo H
    J Cancer Res Clin Oncol; 1992; 118(8):615-20. PubMed ID: 1517282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.